Literature
(1). Blakely, R. L. and Benovic, S. J. 1984. In Folates and pteridines, eds. Blakely, R.L and Benovic, S.J, Vol. 1. Pp. 191-253
(2). Newby, Z. Lee T.T., Morse R.J., Liu Y., Liu L., Venkatraman P., Santi D.V., Finer-Moore J.S., Stroud R.M. 2006. The role of protein dynamics in thymidylate synthase catalysis: variants of conserved 2'-deoxyuridine 5'-monophosphate (dUMP)-binding Tyr-261. Biochemistry 45: 7415-7428
(3). Dowiercial et al, A 2009. Crystal structures of substrate- and sulfate-bound mouse thymidylate synthase. Pteridines 20: 163-167
(4). Finer-Moore, J.S., Maley GF, Maley F, Montfort WR, Stroud RM. 1994. Crystal structure of thymidylate synthase from T4 phage: component of a deoxynucleoside triphosphate-synthesizing complex. Biochemistry 33: 15459-15468
(5). Chu E, Koeller DM, Casey JL, Drake JC, Chabner BA, Elwood PC, Zinn S, Allegra CJ. 1991. Autoregulation of Human Thymidylate Synthase Messenger RNA Translation by Thymidylate Synthase. Cell Biology 88: 8977-8981
(6) Gangjee A, Li W, Kisliuk RL, Cody V, Pace J, Piraino J, Makin J. 2009. Design, synthesis, and X-ray crystal structure of classical and nonclassical 2-amino-4-oxo-5-substituted-6-ethylthieno[2,3-d]pyrimidines as dual thymidylate synthase and dihydrofolate reductase inhibitors and as potential antitumor agents. J.Med.Chem.52: 4892-4902
(7). Etienne, M.C. K Ilc, J-L Formento, P Laurent-Puig, P Formento, S Cheradame, J-L Fischel, G Milano. 2004. Thymidylate synthase and methylenetetrahydrofolate reductase gene polymorphisms: relationships with 5-fluorouracil sensitivity. British Journal of Cancer 90, 526–534.
(8). L. Harvey, J. Finer-Moore, W. Montfort, M. Jones, D. Santi, R. Stroud. 1987. Atomic Structure of Thymidylate Synthase: Target for Rational Drug Design New Series 235: 448-455
(9). G.H Galivan, G.F. Maley, F. Maley. 1976. Demonstration of separate binding sites for the folate coenzymes and deoxynucleotides with inactivated Lactobacillus casei thymidylate synthetase. Biochemistry 15, 356
(10). D. B. Longley, D. P. Harkin, P.G. Johnston. 2003. 5-Fluorouracil: mechanisms of action and clinical strategies. Nat Rev Cancer 3: 330-338
(11). J.S. Finer-Moore, L. Liu, D.L. Birdsall, R. Brem, J. Apfeld, D. Santi, R.M. Stroud. 1998. Contributions of orientation and hydrogen bonding to catalysis in Asn229 mutants of thymidylate synthase. Journal of Molecular Biology 276: 113-129
(12). E. Koehn, L. Perissinotti, S. Moghram, A. Prabhakar, S. Lesely, I. Mathews, A. Kohen. 2012. Folate binding site of flavin-dependent thymidylate synthase PNAS 37
(13). X.Huang, L. Gibson, B. Bell, L. Lovelace, M. Majorette, O. Pena, F. Berger, S. Berger, L. Lebioda. 2010. Replacement of VAL3 in Human Thymidylate Synthase Affects Its Kinetic Properties and Intracellular Stability. Biochemistry 49: 2475–2482
(14). C.A. Almog, A. Waddling, F. Maley, G. F. Maley, P. Van Roey. 2001. Crystal structure of a deletion mutant of human thymidylate synthase_(7-29) and its ternery complex with tomudex and dUMP. Protein Science 10: 988-996
(15) Perry KM, Carreras CW, Chang LC, Santi DV, Stroud RM. 1993. Structures of thymidylate synthase with a C-terminal deletion: role of the C-terminus in alignment of 2'-deoxyuridine 5'-monophosphate and 5,10-methylenetetrahydrofolate. Biochemistry 28: 7116-7125.
(16). Phan J, Koli S, Minor W, Dunlap RB, Berger SH, Lebioda L. 2001. Human thymidylate synthase is in the closed conformation when complexed with dUMP and raltitrexed, an antifolate drug.Biochemistry 40: 1897-18902